| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
MiniMed Group, Inc.
13G/A
Amendment 1
MMED · 60365F109
|
0% |
10/16/2026
Event 10/15/2026
|
|||
|
MiniMed Group, Inc.
13G
MMED · 60365F109
|
90.0% |
5/6/2026
Event 3/31/2026
|
|||
|
Orchestra BioMed Holdings, Inc.
13G/A
Amendment 3
OBIO · 68572M106
|
17.8% |
2/27/2026
Event 12/31/2025
|
|||
| Medtronic plc | 17.8% | ||||
| Covidien Group S.a.r.l. | 17.8% | ||||
|
Anteris Technologies Global Corp.
13D
AVR · 03675P102
|
16.2% |
1/29/2026
Event 1/22/2026
|
|||
| Medtronic plc | 16.2% | ||||
| Covidien Group S.a.r.l. | 16.2% | ||||
|
Orchestra BioMed Holdings, Inc.
13G/A
Amendment 2
OBIO · 68572M106
|
15.4% |
2/14/2025
Event 12/31/2024
|
|||
| Medtronic plc | 15.4% | ||||
| Covidien Group S.a.r.l. | 15.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.